Professor Marcin Ufnal
Medical University of Warsaw, Warsaw (Poland)
Follow
Biography
Marcin Ufnal, MD, PhD, is a Professor at the Medical University of Warsaw. His work spans experimental, clinical, and translational cardiovascular and metabolic disease science, with expertise in pulmonary hypertension, right ventricular failure, heart failure, chronic kidney disease, obesity, and gut microbiota–derived mechanisms relevant to cardiometabolic risk.
He has been a senior author on close to 100 peer-reviewed publications and has received multiple international awards.
In parallel, he has built a drug-development track record in both big pharma and biotech, including leadership roles such as Executive Clinical Research Director and Global Clinical Head. In these positions, he has been responsible for clinical programmes across pulmonary hypertension, heart failure, chronic kidney disease, and anticoagulation.
Contributor content
Presentation
Improving preclinical study design to increase predictive value in heart failure drug development
Presentation
COR-1389, a long-acting selective CRF-2 receptor agonist, in HFpEF with pulmonary hypertension due to left-heart disease: phase 1b randomised trial using wireless pulmonary artery pressure monitoring
Presentation
AZD3427, a novel relaxin receptor agonist and impact on renal perfusion in patients with heart failure with reduced ejection rraction: the phase 1b Re-Perfuse study design
Presentation
AZD3427, a relaxin mimetic in pulmonary hypertension group 2 associated with left heart disease: design and rationale of the phase 2b Re-PHIRE Study
Presentation
